Mangoceuticals (MGRX) Other Working Capital Changes (2023 - 2026)
Mangoceuticals' (MGRX) quarterly Other Working Capital Changes came in at -$13800.0 in Q1 2026, up 20.0% year-on-year from -$11500.4 in Q1 2025, and up 35.06% quarter-over-quarter from -$21251.0 in Q4 2025.
Mangoceuticals (MGRX) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Mangoceuticals has disclosed Other Working Capital Changes across 4 years of filings, most recently posting -$13800.0 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$13800.0, up 20.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$70597.0 (up 41.87% YoY), and the FY2025 annual result was -$74046.0, down 1022.76% from the prior year.
- Other Working Capital Changes came in at -$13800.0 for Q1 2026 at Mangoceuticals, up from -$21251.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $283333.0 in Q2 2024 to a low of -$129363.0 in Q4 2023.
- The 4-year median for Other Working Capital Changes is -$13800.0 (2026), against an average of $15173.8.
- Peak annual rise in Other Working Capital Changes reached 1218.75% in 2024, while the deepest fall reached 178.91% in 2024.
- Mangoceuticals' Other Working Capital Changes stood at -$129363.0 in 2023, then jumped by 131.37% to $40577.0 in 2024, then plunged by 152.37% to -$21251.0 in 2025, then jumped by 35.06% to -$13800.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$13800.0 (Q1 2026), -$21251.0 (Q4 2025), and -$17950.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,800.00 |
| Mar 31, 2026 | -13,800.00 |
| Dec 31, 2025 | -21,251.00 |
| Dec 31, 2025 | -21,251.00 |
| Sep 30, 2025 | -17,950.00 |
| Sep 30, 2025 | -17,950.00 |
| Jun 30, 2025 | -17,596.00 |
| Jun 30, 2025 | -17,596.00 |
| Mar 31, 2025 | -17,249.00 |
| Mar 31, 2025 | -17,249.00 |
| Dec 31, 2024 | 40,577.00 |
| Dec 31, 2024 | 40,577.00 |
| Sep 30, 2024 | 33,333.00 |
| Sep 30, 2024 | 33,333.00 |
| Jun 30, 2024 | 283,333.00 |
| Jun 30, 2024 | 283,333.00 |
| Mar 31, 2024 | -15,412.00 |
| Mar 31, 2024 | -15,412.00 |
| Dec 31, 2023 | -129,363.00 |
| Dec 31, 2023 | -129,363.00 |